Sommaire

• • ·Table of contents

    Page :A4

    
• • ·Editorial board

    Page :A8

    
• • ·Information for authors

    Page :A9

    
• • ·Tackling the challenge of cardiovascular disease burden in developing countries

    Page :1-4

    Salim Yusuf, Mario Vaz, Prem Pais

     
• • ·Coronary revascularization and quality of life

    Page :5-6

    Mark A Hlatky

    
• • ·Coronary artery disease in the developing world

    Page :7-15

    Karen Okrainec, Devi K Banerjee, Mark J Eisenberg

    Résumé Résumé Plan Plan
• • ·Concept and usefulness of cardiovascular risk profiles

    Page :16-26

    William B Kannel, Ralph B D'Agostino, Lisa Sullivan, Peter W.F Wilson

    Résumé Résumé Plan Plan  
• • ·On the move?

    Page :26

     
• • ·Symptoms in acute coronary syndromes: does sex make a difference?

    Page :27-33

    Harshida Patel, Annika Rosengren, Inger Ekman

    Résumé Résumé Plan Plan
• • ·Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials

    Page :34-40

    Adam Splaver, Gervasio A Lamas, Charles H Hennekens

    Résumé Résumé Plan Plan
• • ·Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis

    Page :41-42

    Trip J Meine, J.Kevin Harrison

    Résumé Résumé
• • ·Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design

    Page :43-51

    Gregg C Fonarow, William T Abraham, Nancy M Albert, Wendy A Gattis, Mihai Gheorghiade, Barry Greenberg, Chris M O'Connor, Clyde W Yancy, James Young

    Résumé Résumé Plan Plan  
• • ·Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials

    Page :52-61

    The ONTARGET/TRANSCEND Investigators a * * * e1

    Résumé Résumé Plan Plan  
• • ·Dynamic prognostication in non-ST–elevation acute coronary syndromes: insights from GUSTO-IIB and pursuit

    Page :62-71

    Wei-Ching Chang, Eric Boersma, Christopher B Granger, Robert A Harrington, Robert M Califf, Maarten L Simoons, Neal S Kleiman, Paul W Armstrong, GUSTO-IIb and PURSUIT Investigators

    Résumé Résumé Plan Plan  
• • ·Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: a double-blind, randomized, placebo-controlled study

    Page :72-79

    Graham S Hillis, Claire V Pearson, Scott A Harding, Sheena Sutherland, Christopher A Ludlam, John C Marioni, Robin J Prescott, Keith A.A Fox, Andrew D Flapan

    Résumé Résumé Plan Plan
• • ·Electrocardiographic poor R-wave progression: analysis of multiple criteria reveals little usefulness

    Page :80-85

    Apoor S Gami, Thomas A Holly, James E Rosenthal

    Résumé Résumé Plan Plan  
• • ·Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis

    Page :85

    Alja Vlahović, Aleksandar N Nešković, Milica Dekleva, Biljana Putniković, Zoran B Popović, Petar Otašević, Miodrag Ostojić

    Résumé Résumé Plan Plan  
• • ·Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project

    Page :86-91

    Thao Huynh, Jafna L Cox, David Massel, Cheryl Davies, Joseph Hilbe, Wayne Warnica, Paul A Daly, FASTRAK II Network

    Résumé Résumé Plan Plan
• • ·Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: The Pravastatin in Acute Coronary Treatment (PACT) trial

    Page :91

    Peter L Thompson, Ian Meredith, John Amerena, Terence J Campbell, J.Graeme Sloman, Phillip J Harris, Pravastatin in Acute Coronary Treatment (PACT) Investigators

    Résumé Résumé Plan Plan  
• • ·Relation of age and race with hospital death after acute myocardial infarction

    Page :92-98

    Ajay Manhapra, John G Canto, Viola Vaccarino, Lori Parsons, Catarina I Kiefe, Hal V Barron, William J Rogers, W.Douglas Weaver, Steven Borzak

    Résumé Résumé Plan Plan  
• • ·Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records

    Page :99-104

    Yuka Kiyota, Sebastian Schneeweiss, Robert J Glynn, Carolyn C Cannuscio, Jerry Avorn, Daniel H Solomon

    Résumé Résumé Plan Plan  
• • ·A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy

    Page :105

    Jürgen Pache, Adnan Kastrati, Julinda Mehilli, Hildegard Bollwein, Gjin Ndrepepa, Helmut Schühlen, Stefan Martinoff, Melchior Seyfarth, Stephan Nekolla, Josef Dirschinger, Markus Schwaiger, Albert Schömig

    Résumé Résumé Plan Plan  
• • ·Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial

    Page :105

    Gregory G Schwartz, Michael A Bolognese, Benoit P Tremblay, Richard Caplan, Howard Hutchinson, Ali Raza, Michael Cressman

    Résumé Résumé Plan Plan  
• • ·Cost-effectiveness of using electron beam computed tomography to identify patients at risk for clinical coronary artery disease

    Page :106-113

    Patrick G O'Malley, Bruce A Greenberg, Allen J Taylor

    Résumé Résumé Plan Plan  
• • ·Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial

    Page :114-121

    Magnus Janzon, Lars-Åke Levin, Eva Swahn

    Résumé Résumé Plan Plan  
• • ·Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)

    Page :122-128

    Shelby D Reed, Joëlle Y Friedman, Eric J Velazquez, Ari Gnanasakthy, Robert M Califf, Kevin A Schulman

    Résumé Résumé Plan Plan  
• • ·Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study

    Page :129-136

    Sanjiv Kaul, Roxy Senior, Christian Firschke, Xin-Qun Wang, Jonathan Lindner, Flordeliza S Villanueva, Soroosh Firozan, Michael C Kontos, Allen Taylor, Ian J Nixon, Denny D Watson, Frank E Harrell

    Résumé Résumé Plan Plan  
• • ·In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography

    Page :137-143

    Hiroaki Taniguchi, Yukihiko Momiyama, Zahi A Fayad, Reiko Ohmori, Kazuhiro Ashida, Teruyoshi Kihara, Akiko Hara, Koh Arakawa, Akira Kameyama, Kumiko Noya, Masayoshi Nagata, Haruo Nakamura, Fumitaka Ohsuzu

    Résumé Résumé Plan Plan  
• • ·Biomechanical and echocardiographic characterization of flail mitral leaflet due to myxomatous disease: further evidence for early surgical intervention

    Page :144-150

    William R Mills, J.Edward Barber, Norman B Ratliff, Delos M Cosgrove, Ivan Vesely, Brian P Griffin

    Résumé Résumé Plan Plan  
• • ·Racial differences in the outcomes of patients with diastolic heart failure

    Page :151-156

    Mark A East, Eric D Peterson, Linda K Shaw, Wendy A Gattis, Christopher M O'Connor

    Résumé Résumé Plan Plan  
• • ·The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

    Page :157-164

    J.G.F Cleland, I Findlay, S Jafri, G Sutton, R Falk, C Bulpitt, C Prentice, I Ford, Adele Trainer, P.A Poole-Wilson

    Résumé Résumé Plan Plan  
• • ·Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival

    Page :165-172

    Tom D.J. Smilde, Hans L. Hillege, Gerjan Navis, Frans Boomsma, Dick de Zeeuw, Dirk J. van Veldhuisen

    Résumé Résumé Plan Plan  
• • ·Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension

    Page :172

    C Napoli, V Sica, F de Nigris, O Pignalosa, M Condorelli, L.J Ignarro, A Liguori

    Résumé Résumé Plan Plan  
• • ·Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST–elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18

    Page :173-180

    John V Wylie, Sabina A Murphy, David A Morrow, James A de Lemos, Elliott M Antman, Christopher P Cannon

    Résumé Résumé Plan Plan  
• • ·Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) Pilot Study

    Page :180

    Roberto Lorenzoni, Guido Lazzerini, Franca Cocci, Raffaele De Caterina

    Résumé Résumé Plan Plan  
• • ·Association between transforming growth factor-β1 gene C-509T and T869C polymorphisms and rheumatic heart disease

    Page :181-186

    Hsiang-Tai Chou, Chien-Hsiun Chen, Chang-Hai Tsai, Fuu-Jen Tsai

    Résumé Résumé Plan Plan
• • ·Information for readers

    Page :CO3

    
• • ·Hippocrates on heart failure

    Page :e1

    Tsung O Cheng